20 to 50     : Dose as in normal renal function
10 to 20     : Dose as in normal renal function
<10           : Dose as in normal renal function
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Unlikely dialysability. Dose as in normal renal function.
HD                     :Unlikely dialysability. Dose as in normal renal function.
HDF/high flux   :Unknown dialysability. Dose as in normal renal function
CAV/VVHD      :Unknown dialysability. Dose as in normal renal function
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugs
Anaesthetics: enhanced hypotensive effect
Analgesics: NSAIDs antagonise hypotensive effect
Anti-arrhythmics: increased risk of myocardial depression and bradycardia; increased risk of bradycardia, myocardial depression and AV block with amiodarone
Antidepressants: enhanced hypotensive effect with MAOIsAntihypertensives: enhanced hypotensive effect; increased risk of first dose hypotensive effect with post-synaptic alpha-blockers such as prazosin; increased risk of withdrawal hypertension with clonidine; increased risk of bradycardia and AV block with diltiazem; severe hypotension and heart failure occasionally with nifedipine; asystole, severe hypotension and heart failure with verapamil
Antimalarials: increased risk of bradycardia with mefloquine
Antipsychotics: enhanced hypotensive effect with phenothiazines
Diuretics: enhanced hypotensive effect
Moxisylyte: possibly severe postural hypotensionSevere hypertension with adrenaline and noradrenaline (especially with non-selective beta-blockers) and possibly with dopamineTropisetron: increased risk of ventricular arrhythmias – use with caution
ADMINISTRATION
Reconstition
–
Route
Oral
Rate of Administration
–
Comments
–
OTHER INFORMATION
Use with caution in patients with chronic obstructive airways disease, asthma or diabetesRhabdomyolysis with myoglobinuria has been reported in severe overdosage with oxprenolol